Dataset Information


Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.

ABSTRACT: We studied the therapeutic potential of favipiravir (T-705) for Lassa fever, both alone and in combination with ribavirin. Favipiravir suppressed Lassa virus replication in cell culture by 5 log10 units. In a novel lethal mouse model, it lowered the viremia level and the virus load in organs and normalized levels of cell-damage markers. Treatment with 300 mg/kg per day, commenced 4 days after infection, when the viremia level had reached 4 log10 virus particles/mL, rescued 100% of Lassa virus-infected mice. We found a synergistic interaction between favipiravir and ribavirin in vitro and an increased survival rate and extended survival time when combining suboptimal doses in vivo.

PROVIDER: S-EPMC4760419 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7817048 | BioStudies
| S-EPMC5682919 | BioStudies
| S-EPMC6106425 | BioStudies
2015-01-01 | S-EPMC4600983 | BioStudies
| S-EPMC4724333 | BioStudies
| S-EPMC3191123 | BioStudies
| S-EPMC8266111 | BioStudies
| S-EPMC5075073 | BioStudies
| S-EPMC5580092 | BioStudies
| S-EPMC8067676 | BioStudies